Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
MicroVision Announces Proposed Public Offering of Common Stock
-
CleanSpark Announces Participation at Upcoming Investor Conferences this Summer
-
Borqs Technologies To Accelerate Further Expansion Into Artificial Intelligence of Things (AIoT) Solutions
-
Inspirato to Participate at the 2023 Cantor Fitzgerald Technology Conference
-
TechMediaBreaks – CISO Global Inc. (NASDAQ: CISO) Expected to Build on Growth Momentum with Larger Enterprise Contracts, ‘Highly Favorable’ Landscape
-
Allego to Participate in Upcoming Investor Conferences
-
Innoviz Technologies to Present at Upcoming Investor Conferences
-
American Battery Technology Company Invited to Present at Battery Metals and Recycling Focused Investor Conferences
-
Mondee Announces Closing of Secondary Offering of Common Stock
-
Canaan Inc. to Participate in Cantor Technology Conference on June 14-15, 2023
-
Phunware to Attend the Cantor Fitzgerald Technology Conference on June 14, 2023
-
NewAmsterdam Pharma Announces Closing of Upsized Secondary Offering of Ordinary Shares
-
Form N-CSR CANTOR FITZGERALD SUSTAI For: Mar 31
-
Abacus Life Appoints New Managing Director
-
AEYE to Participate in Upcoming Investor Conferences
-
Bitfarms to Participate in the 2023 Cantor Fitzgerald Technology Conference on June 14 - 15
-
Form SC 13G Healthwell Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
Vaxart (VXRT) Prices 16M Share Offering
-
Vaxart, Inc. Announces Pricing of $15,000,000 Public Offering of Common Stock
-
Vaxart (VXRT) to offer common stock
-
Vaxart, Inc. Announces Proposed Public Offering of Common Stock
-
Yext to Present at Upcoming Investor Conferences
-
TeraWulf (WULF) Announces May 2023 Production and Operations Updates
-
TeraWulf Announces May 2023 Production and Operations Updates
-
Riot Platforms (RIOT) Announces May 2023 Production and Operations Updates
-
Riot Announces May 2023 Production and Operations Updates
-
Arbe to Participate at Upcoming June Investor Conferences
-
Form 8-K Cantor Fitzgerald Income For: Jun 01
-
CSG to Present at Cantor Fitzgerald’s Technology Conference
-
Fulton Bank Moves Forward With Fit-Out at 3.0 University Place With Opening Planned for Late Summer 2023
-
Amprius Sets June 2023 Conference Schedule
-
springbig Announces Closing of $4.0 Million Public Offering
-
CarepathRx Health System Solutions and Evernorth Health Services Forge Strategic Partnership to Enhance Specialty Care for Patients
-
Lyra Therapeutics Announces Closing of $50.0 Million Private Placement
-
Bitfarms Mines 459 BTC in May
-
NuScale Power to Participate in June 2023 Investor Conferences
-
NETSCOUT Announces Participation in Upcoming Investor Events
-
BlackSky to Participate at Three Upcoming Investor Conferences
-
Belite Bio (BLTE) prices 2 million share offering at $15/ADS
-
Belite Bio Announces Pricing of $30 Million Underwritten Public Offering of American Depositary Shares and Warrants
-
Belite Bio (BLTE) to offer ADS and warrants
-
Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares and Warrants
-
Inflection Point Acquisition Corp. II Announces Closing of Upsized $250 Million Initial Public Offering
-
Form NPORT-P CANTOR FITZGERALD SUSTAI For: Mar 31
-
Piper Sandler Continues to Grow Fixed Income Team with Additions of Ervin Pilku and Alex Maldonado
-
Form SC 13D/A BGC Partners, Inc. Filed by: CANTOR FITZGERALD, L. P.
-
Lyra Therapeutics (LYRA) Announces $50.0 Million Private Placement of Common Stock, Warrants
-
Lyra Therapeutics Announces $50.0 Million Private Placement
-
Inflection Point Acquisition Corp. II (IPXXU) Prices Upsized 22M Unit IPO at $10/unit
-
Inflection Point Acquisition Corp. II Announces Pricing of Upsized $220 Million Initial Public Offering

